Ropes & Gray Advises Evergreen Nephrology in $130 Million Fund Raise

In The News
January 9, 2025

Ropes & Gray represented Evergreen Nephrology, a leader in value-based kidney care, in the company’s $130 million fund raise led by Rubicon Founders, Oak HC/FT, and a group of existing investors with the addition of K2 HealthVentures. The transaction was announced in a Jan. 7 press release.

Evergreen Nephrology partners with nephrologists and payors to provide care for patients with chronic and end-stage kidney disease. Operating across 24 states with a network of over 900 providers, Evergreen delivers personalized, value-based care designed to empower patients and improve outcomes.

The team was led by finance partner Greg Bauer, venture capital & emerging companies partner Brad Flint, executive compensation & employee benefits partner Pascal Mayer, tax partners Pam Glazier and Tristan Evans-Wilent, and health care partner Devin Cohen.